Lynne Napatalung

631 total citations · 1 hit paper
18 papers, 327 citations indexed

About

Lynne Napatalung is a scholar working on Urology, Dermatology and Cell Biology. According to data from OpenAlex, Lynne Napatalung has authored 18 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Urology, 10 papers in Dermatology and 8 papers in Cell Biology. Recurrent topics in Lynne Napatalung's work include Hair Growth and Disorders (14 papers), melanin and skin pigmentation (7 papers) and Dermatology and Skin Diseases (6 papers). Lynne Napatalung is often cited by papers focused on Hair Growth and Disorders (14 papers), melanin and skin pigmentation (7 papers) and Dermatology and Skin Diseases (6 papers). Lynne Napatalung collaborates with scholars based in United States, Australia and Canada. Lynne Napatalung's co-authors include Samuel H. Zwillich, Vanja Sikirica, Robert Wołk, Xingqi Zhang, Rodney Sinclair, Dalia Wajsbrot, Natasha Atanaskova Mesinkovska, Jacek C. Szepietowski, Amy Freyman and Brett King and has published in prestigious journals such as The Lancet, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

Lynne Napatalung

16 papers receiving 324 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial

2023 134 citations Brett King, Xingqi Zhang et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynne Napatalung United States	7	193	166	101	46	45	18	327
Youyu Sheng China	11	235 1.2×	158 1.0×	71 0.7×	36 0.8×	47 1.0×	25	336
Grace W. Kimmel United States	9	139 0.7×	202 1.2×	79 0.8×	54 1.2×	124 2.8×	15	349
Saori Itoi Japan	8	51 0.3×	139 0.8×	116 1.1×	32 0.7×	123 2.7×	17	321
Deanna Kornacki United States	6	37 0.2×	89 0.5×	125 1.2×	37 0.8×	77 1.7×	23	239
Manoj Kumar Tembhre India	8	85 0.4×	111 0.7×	173 1.7×	29 0.6×	191 4.2×	14	333
Markus Böhm Germany	10	254 1.3×	197 1.2×	88 0.9×	51 1.1×	53 1.2×	15	392
Dalia Ahmed Bassiouny Egypt	12	33 0.2×	377 2.3×	304 3.0×	33 0.7×	174 3.9×	24	616
Raya Shalaginov Israel	8	260 1.3×	231 1.4×	126 1.2×	54 1.2×	160 3.6×	9	465
Andrea Tovar‐Garza United States	10	50 0.3×	380 2.3×	392 3.9×	23 0.5×	217 4.8×	14	663
Bedia Assy Israel	10	440 2.3×	352 2.1×	195 1.9×	91 2.0×	237 5.3×	12	697

Countries citing papers authored by Lynne Napatalung

Since Specialization

Citations

This map shows the geographic impact of Lynne Napatalung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynne Napatalung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynne Napatalung more than expected).

Fields of papers citing papers by Lynne Napatalung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynne Napatalung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynne Napatalung. The network helps show where Lynne Napatalung may publish in the future.

Co-authorship network of co-authors of Lynne Napatalung

This figure shows the co-authorship network connecting the top 25 collaborators of Lynne Napatalung. A scholar is included among the top collaborators of Lynne Napatalung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynne Napatalung. Lynne Napatalung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Vañó‐Galván, Sergio, Andrew G. Messenger, Helen Tran, et al.. (2025). Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata. Dermatology and Therapy. 15(6). 1543–1553. 1 indexed citations

King, Brett, Amy McMichael, Rodney Sinclair, et al.. (2025). Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata. Dermatology and Therapy. 15(12). 3793–3803.

Tran, Helen, Lynne Napatalung, Griffith Bell, et al.. (2025). Perceived Stigma Among Adults With Alopecia Areata in the United States. The Journal of Dermatology. 52(7). 1185–1191. 1 indexed citations

Yamaguchi, Yuji, Elena Peeva, Lynne Napatalung, et al.. (2024). Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension study. Journal of the American Academy of Dermatology. 92(4). 781–789.

Sinclair, Rodney, Ernest H. Law, Xingqi Zhang, et al.. (2024). Patient-Reported Satisfaction with Hair Regrowth in a Study of Ritlecitinib in Alopecia Areata: Results from ALLEGRO-2b/3. Dermatology. 240(5-6). 1–11. 2 indexed citations

Yamaguchi, Yuji, Elena Peeva, Lynne Napatalung, et al.. (2024). 648 - Response to ritlecitinib with or without narrow band ultraviolet B (nbUVB) add-on therapy in patients with active non-segmental vitiligo (NSV). British Journal of Dermatology. 191(Supplement_2). 1 indexed citations

Davis, Keith L., Andrew G. Messenger, Sergio Vañó‐Galván, et al.. (2024). Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO). SKIN The Journal of Cutaneous Medicine. 8(2). s395–s395. 1 indexed citations

Anderson, Samira, Guido Cavaletti, Linda J. Hood, et al.. (2024). A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata. Pharmacology Research & Perspectives. 12(4). e1204–e1204. 4 indexed citations

George, Prethibha, Robert Wołk, Lynne Napatalung, et al.. (2024). The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016. Dermatology and Therapy. 14(4). 993–1006. 1 indexed citations

10.

King, Brett, Xingqi Zhang, Jacek C. Szepietowski, et al.. (2023). A Plain Language Summary on Ritlecitinib Treatment for Adults and Adolescents with Alopecia Areata. Immunotherapy. 15(14). 1093–1103. 4 indexed citations

11.

Patel, Reema, Amit G. Pandya, Vanja Sikirica, et al.. (2023). Prevalence of Vitiligo among Children and Adolescents in the United States. Dermatology. 239(2). 227–234. 12 indexed citations

12.

King, Brett, Xingqi Zhang, Jacek C. Szepietowski, et al.. (2023). Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial. The Lancet. 401(10387). 1518–1529. 134 indexed citations breakdown →

13.

King, Brett, Edmund J. Pezalla, Helen Tran, et al.. (2023). Overview of alopecia areata for managed care and payer stakeholders in the United States. Journal of Managed Care & Specialty Pharmacy. 29(7). 848–856. 2 indexed citations

14.

George, Prethibha, Qing Liu, Charles Wentworth, et al.. (2023). Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database. The Journal of Dermatology. 50(9). 1121–1128. 9 indexed citations

15.

George, Prethibha, Qing Liu, Charles Wentworth, et al.. (2023). Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database. Dermatology and Therapy. 13(8). 1733–1746. 8 indexed citations

16.

Campos‐Alberto, Eduardo, Tomohiro Hirose, Lynne Napatalung, & Manabu Ohyama. (2022). Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database. The Journal of Dermatology. 50(1). 37–45. 22 indexed citations

17.

Mostaghimi, Arash, Lynne Napatalung, Vanja Sikirica, et al.. (2021). Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review. Dermatology and Therapy. 11(3). 867–883. 56 indexed citations

18.

Gandhi, Kavita, Khaled Ezzedine, Kathryn Anastassopoulos, et al.. (2021). Prevalence of Vitiligo Among Adults in the United States. JAMA Dermatology. 158(1). 43–43. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact